Complications associated with implantable cardioverter-defibrillator replacement in response to device advisories

Paul A Gould1, Andrew D Krahn,

  • 1Division of Cardiology, Department of Medicine, University of Western Ontario, London.

JAMA
|April 28, 2006
PubMed

Insights

Implantable cardioverter-defibrillator (ICD) generator replacement due to advisories has a high complication rate, including death. This highlights the need for new guidelines for managing patients with advisory ICDs.

Area of Science:

  • Cardiology
  • Medical Device Safety
  • Electrophysiology

Background:

  • Recent implantable cardioverter-defibrillator (ICD) advisories and recalls create management challenges for physicians.
  • No specific guidelines or outcome data exist for current management strategies of advisory ICDs.
  • The complication risk of ICD generator replacement in this population remains unassessed.

Purpose of the Study:

  • To determine the complication rate associated with ICD generator replacement specifically for current ICD advisories.
  • To provide data for developing management guidelines for patients with advisory ICDs.

Main Methods:

  • A survey of 17 Canadian ICD implanting centers was conducted.
  • Data on complication rates from elective ICD generator replacements due to advisories were collected from October 2004 to October 2005.
  • Complications were tracked during follow-up after generator replacement.

Main Results:

  • Out of 533 patients who had advisory ICDs replaced, 8.1% experienced complications.
  • Major complications requiring reoperation occurred in 5.8% of patients, with 2 deaths reported due to pocket infection.
  • Minor complications were observed in 2.3% of patients.

Conclusions:

  • ICD generator replacement in patients with advisory devices is linked to a significant complication rate, including mortality.
  • These findings underscore the necessity of considering complication risks when developing treatment guidelines for advisory ICDs.
  • Further research is needed to establish optimal management strategies for patients with recalled or advisory ICDs.
Abstract

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy01:26

Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy

Continuous Renal Replacement Therapy (CRRT) is an essential intervention for patients experiencing severe kidney dysfunction. This therapy offers a continuous mechanism for removing fluids and toxins from the bloodstream, leveraging the patient’s blood pressure to facilitate filtration through a specialized filter. This method contrasts with intermittent dialysis, providing a gentler and more consistent removal of waste products and excess fluid, which is particularly beneficial in critically...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...